Prevalence of metabolic syndrome and its different components in patients with acute coronary syndrome


  • Gaurav Jain Student, SS Institute of Medical Sciences, Davangere, Karnataka, India
  • Balaji D. More Department of Pharmacology, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India



Coronary artery disease, Diabetes mellitus, Hypertension, Metabolic syndrome, Prevalence, Triglycerides


Background: Several components of the Metabolic Syndrome (MetS) are risk factor for cardiovascular diseases. So, this study was conducted to evaluate the prevalence of MetS and its components in patients with CAD.

Methods: Author included all patients admitted with Acute Coronary Syndrome (ACS), who had CAD confirmed by coronary angiography. They were divided into two groups according to presence or absence of MetS based on International Diabetes Federation criteria. The prevalence of MetS and its individual components was estimated.

Results: It was observed that there is a high prevalence of MetS (66%) in patients admitted with ACS. Metabolic syndrome is more prevalent in female patients (82.4%) than in male patients (57.6%) with ACS. Hypertension is the most prevalent (87.9) component of MetS. Diabetes Mellitus (DM) is the 2nd most prevalent (83.3%) component of MetS. About 65.2% patients with MetS had abnormally raised triglyceride levels and 32(48.5%) had abnormally low HDL-cholesterol level.  Among the MetS 38(57.6%) had abnormal waist circumference.  Among the study group, the most common triad of MetS components was DM + HTN + abnormal TG. There is significant association between MetS and microalbuminuria, with incidence of 22(33.3%) in this study. Similarly, a significant association between DM and microalbuminuria, 23(33.8%) was observed.

Conclusions: This study confirms a very high prevalence of MetS in Indian patients with CAD. The prevalence of the risk factors was higher in CAD patients with MetS.


Montazerifar F, Bolouri A, Mahmoudi Mozaffar M, Karajibani M. The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients. Cardiol Res. 2016;7(6):202-8.

Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004 Jan 27;109(3):433-8.

Meigs JB, Wilson PW, Nathan DM, D’Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003 Aug 1;52(8):2160-7.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.

Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscl Thromb. 2005;12(6):295-300.

Won KB, Chang HJ, Sung J, Shin S, Cho IJ, Shim CY, et al. Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population. BMC Cardio Dis. 2014 Dec;14(1):105.

Sundaramoorthy V, Mambatta AK, Chidambaram Y, Gopalan R, Menon S. Prevalence of metabolic syndrome in patients with premature coronary artery disease proven by coronary angiogram. Int J Res Med Sci. 2017;5(11):5021-5.

Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu Blackett K, et al. World Health Organization definition of myocardial infarction: 2008–09 revision. Int J Epidemiol. 2010 Oct 4;40(1):139-46.

Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im) precision: A statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task force for the definition of myocardial infarction. Clin Chem. 2010 Jun 1;56(6):941-3.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.

Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004 Sep 7;110(10):1245-50.

Al Suwaidi J, Zubaid M, El‐Menyar AA, Singh R, Rashed W, Ridha M, et al. Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six middle eastern countries. J Clin Hype. 2010 Nov;12(11):890-9.

Sinha SK, Goel A, Madaan A, Thakur R, Krishna V, Singh K, et al. Prevalence of metabolic syndrome and its clinical and angiographic profile in patients with naive acute coronary syndrome in North Indian population. J Clin Med Res. 2016 Sep;8(9):667.

Danciu SC, Iqbal FM, Manankil MF, Koul S, Raghuvir R, Herrera CJ. Metabolic Syndrome in Younger Patients with Acute Coronary Syndrome. Eur J General Med. 2012 Mar 1;9(1).

Pandey S, Baral N, Majhi S, Acharya P, Karki P, Shrestha S, et al. Prevalence of the metabolic syndrome in acute myocardial infarction and its impact on hospital outcomes. Int J Diab Develop Count. 2009 Apr;29(2):52.

Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol. 2007 Apr 1;99(7):885-9.

Amarasinghe S, Sandrasegarampillai B, Arasaratnam V. Metabolic syndrome among Jaffna Tamil community, Sri Lanka. Ind J Endocrinol Metab. 2015 Sep;19(5):663.

Yasar AS, Bilen E, Bilge M, Arslantas U, Karakas F. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction. Coron Artery Dis. 2009 Sep 1;20(6):387-91.

Dohi T, Miyauchi K, Kasai T, Kajimoto K, Kubota N, Tamura H, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circul J. 2009;73(8):1454-8.

Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endo Rev. 2008 Dec 1;29(7):777-822.

Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R, Nikhoo A, et al. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diab Metab Dis. 2013 Dec;12(1):11.

Žaliūnas R, Šlapikas R, Babarskienė R, Šlapikienė B, Lukšienė D, Milvidaitė I, et al. The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes. Medicina. 2008;44(7):521.

Jover A, Corbella E, Munoz A, Millan J, Pinto X, Mangas A, et al. Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome. Rev Esp Cardiol. 2011;64(7):579-86.

Moussouami SI, Bouhika EJ, Nsompi F, Kayilou JM, Mbemba F, Massamba A. Prevalence and risk factors of cardiovascular diseases in the Congo-Brazzaville Pygmies. World J Cardio Dis. 2016 Jul 7;6(07):211.

Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM. Metabolic syndrome in young Asian Indian patients with myocardial infarction. Cardio J Africa. 2007 Jul;18(4):228.

Zhang Y, Hong J, Gu W, Gui M, Chen Y, Zhang Y, et al. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. Endocrine. 2009 Oct 1;36(2):233-8.

Osei-Yeboah J, Owiredu WK, Norgbe GK, Yao Lokpo S, Gyamfi J, Alote Allotey E, et al. The prevalence of metabolic syndrome and its components among people with type 2 diabetes in the ho municipality, Ghana: a cross-sectional study. Int J Chron Dis. 2017;2017.

Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003 May 1;52(5):1210-4.

Ebrahimi M, Kazemi-Bajestani SM, Ghayour-Mobarhan M, Moohebati M, Paydar R, Azimi-Nezhad M, et al. Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: population-specific definitions are required. Sci World J. 2009;9:86-96.

Prasad SB, Fahrtash F, Malaiapan Y, Meredith IT, Cameron J. Obesity and the metabolic syndrome in patients with acute myocardial infarction. Int J Cardiol. 2010;144(3):450-1.

Babić Z, Pavlov M, Bulj N, Nikolić Heitzler V, Mitrović V, Hamm C, et al. Metabolic syndrome and outcome in patients with acute myocardial infarction. Acta Clinica Croatica. 2011;50(2):193-8.

Goswami B TD, Tyagi S, Mallika V. Prevalence of metabolic syndrome in patients with angiographically proven coronary artery disease presenting to a tertiary care hospital in Delhi, India. Diab Meta Synd. 2011;5(2):53-60.

Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, et al. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 1991 Oct 1;90(2-3):189-96.

World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. Available at:;jsessionid=9626EC0A66EECA7E5446E7A50E703D9E?sequence=1

Li XH, Lin HY, Wang SH, Guan LY, Wang YB. Association of microalbuminuria with metabolic syndrome among aged population. BioMed Res Int. 2016;2016.

Sheng CS, Hu BC, Fan WX, Zou J, Li Y, Wang JG. Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetol Metab Synd. 2011 Dec;3(1):6.

Chowta NK, Pant P, Chowta MN. Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance. Ind J Nephrol. 2009 Apr;19(2):53.

Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, Sharma T. Albuminuria and diabetic retinopathy in type 2 diabetes mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Synd. 2011 Dec;3(1):9.






Original Research Articles